Related Experiment Videos
Sodium/iodide symporter (NIS) and cytokines
1Department of Internal Medicine, University Clinic of Frankfurt/Main, Germany. Schumm-Draeger@em.uni-frankfurt.de
Summary
Thyroid-stimulating hormone (TSH) regulates rat NIS gene expression, but cytokines like IL-1beta and IL-6 can alter this. NIS is implicated as an autoantigen in autoimmune thyroid diseases, requiring further in vivo study.
Area of Science:
- Endocrinology
- Immunology
- Molecular Biology
Background:
- Thyroid-stimulating hormone (TSH) is known to upregulate rat NIS gene expression.
- Cytokines can modulate TSH-induced NIS gene expression, influencing thyroid function.
- NIS expression is observed in thyroid tissue of patients with autoimmune thyroid diseases, including Graves' disease.
Purpose of the Study:
- To investigate the modulatory effects of cytokines on NIS gene expression.
- To explore the role of NIS as a potential autoantigen in autoimmune thyroid diseases.
- To evaluate the impact of specific cytokines (IL-1beta and IL-6) on NIS expression and function.
Main Methods:
- In vitro studies using FRTL-5 cells to assess NIS mRNA expression and iodide accumulation.
- Ex vivo analysis of rat NIS mRNA distribution in various tissue samples.
- Comparison of NIS expression patterns with known thyroid autoantigens like TPO and Tg.
Main Results:
- TSH upregulates rat NIS gene expression, with variable ex vivo mRNA levels.
- IL-1beta and IL-6 decrease NIS mRNA expression in TSH-stimulated cells.
- IL-1beta suppresses iodide accumulation, while IL-6 does not affect NIS functional activity.
Conclusions:
- Cytokines significantly modulate NIS gene expression and function, particularly in the context of TSH stimulation.
- NIS exhibits characteristics of an autoantigen in autoimmune thyroid diseases, similar to TPO and Tg.
- Further in vivo studies and clinical trials are necessary to elucidate the mechanisms of NIS regulation by cytokines in thyroid autoimmune diseases.